Extracellular cytochrome c, a mitochondrial apoptosis-related protein, induces arthritis

Rheumatology

Volumn 44, Issue 1, 2005, Pages 32-39

  Pullerits, Rille ^a   Bokarewa, M ^a   Jonsson, I M ^a   Verdrengh, M ^a   Tarkowski, A ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Arthritis; Chemokine; Cytochrome c; Cytokine; Inflammation; NF B

Indexed keywords

CD11B ANTIGEN; CHEMOKINE; CYTOCHROME C; CYTOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOCHONDRIAL PROTEIN;

ADULT; AGED; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BLOOD ANALYSIS; CELL STIMULATION; CELL TRANSPORT; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DEPLETION; ENZYME ACTIVATION; ENZYME LINKED IMMUNOSORBENT ASSAY; EXTRACELLULAR SPACE; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; MONOCYTE; MOUSE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RHEUMATOID ARTHRITIS; SPLEEN CELL; SYNOVIAL FLUID LEVEL; SYNOVITIS; SYNOVIUM;

ADULT; AGED; ANIMALS; APOPTOSIS; ARTHRITIS, EXPERIMENTAL; ARTHRITIS, RHEUMATOID; CELLS, CULTURED; CHEMOKINES; CYTOCHROMES C; ELECTROPHORETIC MOBILITY SHIFT ASSAY; EXTRACELLULAR FLUID; FEMALE; HUMANS; INJECTIONS, INTRA-ARTICULAR; MICE; MICE, INBRED BALB C; MIDDLE AGED; NEUTROPHILS; NF-KAPPA B; SPLEEN; SYNOVIAL FLUID;

EID: 12344270141     PISSN: 14620324     EISSN: None     Source Type: Journal    
DOI: 10.1093/rheumatology/keh406     Document Type: Article

References (38)

1. Evans MJ, Scarpulla RC. The human somatic cytochrome c gene: two classes of processed pseudogenes demarcate a period of rapid molecular evolution. Proc Natl Acad Sci USA 1988;85:9625-9.
2. Carlson SS, Mross GA, Wilson AC et al. Primary structure of mouse, rat, and guinea pig cytochrome c. Biochemistry 1977;16:1437-42.
3. Tanaka Y, Ashikari T, Shibano Y, Amachi T, Yoshizumi H, Matsubara H. Construction of a human cytochrome c gene and its functional expression in Saccharomyces cerevisiae. J Biochem (Tokyo) 1988;103:954-61.
4. Liu X, Kim CN, Yang J, Jemmerson R, Wang X. Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome c. Cell 1996;86:147-57.
5. Zou H, Li Y, Liu X, Wang X. An APAF-1 cytochrome c multimeric complex is a functional apoptosome that activates procaspase-9. J Biol Chem 1999;274:11549-56.
6. Hatefi Y. The mitochondrial electron transport and oxidative phosphorylation system. Annu Rev Biochem 1985;54:1015-69.
7. Green DR, Reed JC. Mitochondria and apoptosis. Science 1998;281:1309-12.
8. Jemmerson R, LaPlante B, Treeful A. Release of intact, monomeric cytochrome c from apoptotic and necrotic cells. Cell Death Differ 2002;9:538-48.
9. Li YZ, Li CJ, Pinto AV, Pardee AB. Release of mitochondrial cyrochrome C in both apoptosis and necrosis induced by beta-lapachone in human carcinoma cells. Mol Med 1999;5:232-9.
10. Renz A, Berdel WE, Kreuter M, Belka C, Schulze-Osthoff K, Los M. Rapid extracellular release of cytochrome c is specific for apoptosis and marks cell death in vivo. Blood 2001;98:1542-8.
11. Alleyne T, Joseph J, Sampson V. Cytochrome-c detection: a diagnostic marker for myocardial infarction. Appl Biochem Biotechnol 2001;90:97-105.
12. Andrianova IG, Sidorova ND. [Cytochrome C and the possibility of its use in clinical practice]. Klin Med (Mosk) 1974;52:12-6.
13. Gvatua NA, Komissarenko SV, Skok MV, Solonenko IN, Veselovskaia LD, Galitskaia AK. [Determination of the concentration of cytochrome c and its antibodies in the blood serum for the diagnosis and prognosis of complications in myocardial infarct patients]. Ter Arkh 1990;62:58-61.
14. Pope RM. Apoptosis as a therapeutic tool in rheumatoid arthritis. Nat Rev Immunol 2002;2:527-35.
15. Pullerits R, Jonsson IM, Verdrengh M et al. High mobility group box chromosomal protein 1, a DNA binding cytokine, induces arthritis. Arthritis Rheum 2003;48:1693-700.
16. van't Went JW, Linde I, Leijh PC, van Furth R. Effect of irradiation, cyclophosphamide, and etoposide (VP-16) on number of peripheral blood and peritoneal leukocytes in mice under normal conditions and during acute inflammatory reaction. Inflammation 1989;13:1-14.
17. Verdrengh M, Tarkowski A. Role of macrophages in Staphylococcus aureus-induced arthritis and sepsis. Arthritis Rheum 2000;43:2276-82.
18. Verdrengh M, Tarkowski A. Role of neutrophils in experimental septicemia and septic arthritis induced by Staphylococcus aureus. Infect Immun 1997;65:2517-21.
19. Deng GM, Tarkowski A. The features of arthritis induced by CpG motifs in bacterial DNA. Arthritis Rheum 2000;43:356-64.
20. Jonsson R, Tarkowski A, Klareskog L. A demineralization procedure for immunohistopathological use. EDTA treatment preserves lymphoid cell surface antigens. J Immunol Methods 1986;88:109-14.
21. Pierres A, Naquet P, Van Agthoven A et al. A rat anti-mouse T4 monoclonal antibody (H129.19) inhibits the proliferation of Ia-reactive T cell clones and delineates two phenotypically distinct (T4+, Lyt-2,3-, and T4-, Lyt-2,3+) subsets among anti-Ia cytolytic T cell clones. J Immunol 1984;132:2775-82.
22. Bergquist J, Ohlsson B, Tarkowski A. Nuclear factor-kappa B is involved in the catecholaminergic suppression of immunocompetent cells. Ann NY Acad Sci 2000;917:281-9.
23. Lopez-Franco O, Suzuki Y, Sanjuan G et al. Nuclear factor-kappa B inhibitors as potential novel anti-inflammatory agents for the treatment of immune glomerulonephritis. Am J Pathol 2002;161:1497-505.
24. Aarden LA, De Groot ER, Schaap OL, Lansdorp PM. Production of hybridoma growth factor by human monocytes. Eur J Immunol 1987;17:1411-6.
25. Helle M, Boeije L, Aarden LA. Functional discrimination between interleukin 6 and interleukin 1. Eur J Immunol 1988;18:1535-40.
26. Li Q, Verma IM. NF-kappaB regulation in the immune system. Nat Rev Immunol 2002;2:725-34.
27. Ghosh S, May MJ, Kopp EB. NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses. Annu Rev Immunol 1998;16:225-60.
28. Feldmann M, Brennan FM, Maini RN. Role of cytokines in rheumatoid arthritis. Annu Rev Immunol 1996;14:397-440.
29. Volin MV, Shah MR, Tokuhira M, Haines GK, Woods JM, Koch AE. RANTES expression and contribution to monocyte chemotaxis in arthritis. Clin Immunol Immunopathol 1998;89:44-53.
30. Koch AE, Kunkel SL, Harlow LA et al. Macrophage inflammatory protein-1 alpha. A novel chemotactic cytokine for macrophages in rheumatoid arthritis. J Clin Invest 1994;93:921-8.
31. Rollins BJ. Monocyte chemoattractant protein 1: a potential regulator of monocyte recruitment in inflammatory disease. Mol Med Today 1996;2:198-204.
32. Barnes DA, Tse J, Kaufhold M et al. Polyclonal antibody directed against human RANTES ameliorates disease in the Lewis rat adjuvant-induced arthritis model. J Clin Invest 1998;101:2910-9.
33. Baeuerle PA, Henkel T. Function and activation of NF-kappa B in the immune system. Annu Rev Immunol 1994;12:141-79.
34. Campbell IK, Gerondakis S, O'Donnell K, Wicks IP. Distinct roles for the NF-kappaB1 (p50) and c-Rel transcription factors in inflammatory arthritis. J Clin Invest 2000;105:1799-806.
35. Banda NK, Kraus D, Vondracek A et al. Mechanisms of effects of complement inhibition in marine collagen-induced arthritis. Arthritis Rheum 2002;46:3065-75.
36. Hedberg H. Studies on the depressed hemolytic complement activity of synovial fluid in adult rheumatoid arthritis. Acta Rheumatol Scand 1963;43:165-93.
37. Pereverzev MO, Vygodina TV, Konstantinov AA, Skulachev VP. Cytochrome c, an ideal antioxidant. Biochem Soc Trans 2003; 31:1312-5.
38. Korshunov SS, Krasnikov BF, Pereverzev MO, Skulachev VP. The antioxidant functions of cytochrome c. FEBS Lett 1999;462:192-8.